ArticleNews reportPHN-01132026-10-29 03:17 CT
Lilly’s retatrutide shows greater A1C reduction and weight loss than Ozempic in Phase 3 trial
Source · Express Pharma
TLDR
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.